Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2021 1
2022 6
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Combination therapy with exenatide decreases the dapagliflozin-induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial.
van Ruiten CC, Veltman DJ, Wijdeveld M, Ten Kulve JS, Kramer MHH, Nieuwdorp M, IJzerman RG. van Ruiten CC, et al. Diabetes Obes Metab. 2022 Aug;24(8):1588-1597. doi: 10.1111/dom.14732. Epub 2022 May 23. Diabetes Obes Metab. 2022. PMID: 35491524 Free PMC article. Clinical Trial.
Personalized Dietary Advice to Increase Protein Intake in Older Adults Does Not Affect the Gut Microbiota, Appetite or Central Processing of Food Stimuli in Community-Dwelling Older Adults: A Six-Month Randomized Controlled Trial.
Fluitman KS, Wijdeveld M, Davids M, van Ruiten CC, Reinders I, Wijnhoven HAH, Keijser BJF, Visser M, Nieuwdorp M, IJzerman RG. Fluitman KS, et al. Among authors: van ruiten cc. Nutrients. 2023 Jan 9;15(2):332. doi: 10.3390/nu15020332. Nutrients. 2023. PMID: 36678203 Free PMC article. Clinical Trial.
Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial.
van Ruiten CC, van der Aart-van der Beek AB, IJzerman RG, Nieuwdorp M, Hoogenberg K, van Raalte DH, Heerspink HJL. van Ruiten CC, et al. Diabetes Obes Metab. 2021 Aug;23(8):1851-1858. doi: 10.1111/dom.14410. Epub 2021 May 14. Diabetes Obes Metab. 2021. PMID: 33908691 Free PMC article. Clinical Trial.